| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | calcipotriol/betamethasone (Enstilar®) |
| Formulation | 50 micrograms/0.5 mg cutaneous foam |
| Reference number | 3027 |
| Indication | Topical treatment of psoriasis vulgaris in adults |
| Company | LEO Pharma |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 25/02/2016 |